Source: Health Products Regulatory Authority (IE) Revision Year: 2020 Publisher: Nikkiso Belgium, Industriepark 6, 3300 Tienen, Belgium, Tel (Belgium): +32 (0)16 781770, Tel (Ireland): +353 1800 939112
Pharmacotherapeutic group: Haemofiltrates
ATC code: B05ZB
Accusol 35is pharmacologically inactive. The solution consists of ions that are present at concentrations similar to physiological level in plasma.
As substitution solution, Accusol 35 provides a continuous source of electrolytes and water for hydration and acts as an alkalinising agent.
As dialysis solution, Accusol 35 removes metabolic waste products from the blood and helps to manage the serum electrolytes and/or fluid imbalances.
Not relevant as the active ingredients of Accusol 35 are pharmacologically inactive and near to physiological plasma concentrations.
There are no preclinical data considered relevant to clinical safety beyond data included in other sections of the SPC.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
